Literature DB >> 15355869

Aspergillosis in "nonimmunocompromised" critically ill patients.

David W Denning.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15355869     DOI： 10.1164/rccm.2407004

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  3 in total

1.  In vitro release by Aspergillus fumigatus of galactofuranose antigens, 1,3-beta-D-glucan, and DNA, surrogate markers used for diagnosis of invasive aspergillosis.

Authors:  Monique A S H Mennink-Kersten; Dorien Ruegebrink; Nazhat Wasei; Willem J G Melchers; Paul E Verweij
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

Review 2.  Identification and management of invasive mycoses in internal medicine: a road-map for physicians.

Authors:  Marco Falcone; Ercole Concia; Ido Iori; Giuliana Lo Cascio; Antonino Mazzone; Federico Pea; Francesco Violi; Mario Venditti
Journal:  Intern Emerg Med       Date:  2014-05-29       Impact factor: 3.397

Review 3.  Infections in chronic lung diseases.

Authors:  G Iyer Parameswaran; Timothy F Murphy
Journal:  Infect Dis Clin North Am       Date:  2007-09       Impact factor: 5.982
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.